Correlation Between 180 Life and Unicycive Therapeutics

Can any of the company-specific risk be diversified away by investing in both 180 Life and Unicycive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 180 Life and Unicycive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between 180 Life Sciences and Unicycive Therapeutics, you can compare the effects of market volatilities on 180 Life and Unicycive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 180 Life with a short position of Unicycive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 180 Life and Unicycive Therapeutics.

Diversification Opportunities for 180 Life and Unicycive Therapeutics

-0.36

Correlation Coefficient

180 Life  Unicycive Therapeutics

Very good diversification

The 3 months correlation between 180 and Unicycive is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding 180 Life Sciences and Unicycive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Unicycive Therapeutics and 180 Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 180 Life Sciences are associated (or correlated) with Unicycive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Unicycive Therapeutics has no effect on the direction of 180 Life i.e., 180 Life and Unicycive Therapeutics go up and down completely randomly.

Pair Corralation between 180 Life and Unicycive Therapeutics

Given the investment horizon of 90 days 180 Life Sciences is expected to under-perform the Unicycive Therapeutics. In addition to that, 180 Life is 2.57 times more volatile than Unicycive Therapeutics. It trades about -0.01 of its total potential returns per unit of risk. Unicycive Therapeutics is currently generating about 0.14 per unit of volatility. If you would invest  69.00  in Unicycive Therapeutics on October 6, 2024 and sell it today you would earn a total of  10.00  from holding Unicycive Therapeutics or generate 14.49% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

180 Life Sciences  vs.  Unicycive Therapeutics

180 Life Sciences

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in 180 Life Sciences are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, 180 Life reported solid returns over the last few months and may actually be approaching a breakup point.

Unicycive Therapeutics

Risk-Adjusted Performance

19 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Unicycive Therapeutics are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental indicators, Unicycive Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with 180 Life and Unicycive Therapeutics

The main advantage of trading using opposite 180 Life and Unicycive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 180 Life position performs unexpectedly, Unicycive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Unicycive Therapeutics will offset losses from the drop in Unicycive Therapeutics' long position.

The idea behind 180 Life Sciences and Unicycive Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.